News

The European Medicines Agency (EMA) and the European Medicines regulatory network have announced the lifting of COVID-19 business continuity measures, signifying a step towards normalizing regulatory processes as pandemic trends shift. These measures were introduced in 2020 to prioritize...

Pharma.Aero and Neutral Air Partner have come together to work collaboratively towards improving the reliability, security and speed of life science and MedTech-related airfreight shipping. Under their memorandum of understanding (MoU), the two partners will conduct joint research and studies,...

Bayer and Bicycle Therapeutics Limited, a biotechnology company pioneering a new and differentiated class of therapeutics by utilizing proprietary bicyclic peptides technology (Bicycle), have entered a strategic collaboration to discover, develop, manufacture, and commercialize Bicycle radio conjugates for multiple...

NewBiologix SA launched as a technology innovation company developing a proprietary and breakthrough platform for the advanced engineering of cell lines used to manufacture gene and cell therapies. The launch also includes the completion of a custom built 19,000...

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), entered into a collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi and Wilson Wolf that brings together...

Ascend Gene & Cell Therapies, a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy technologies, announces  that it has launched as a facilitator for gene therapy companies to help...

nVentic, the inventory optimization specialist, has today launched its 2023 Big Pharma Inventory Benchmarking Report. The report, which analyses the published corporate reports of 28 major pharmaceutical manufacturers, including Merck, AstraZeneca and Pfizer, is an annual look at the...